Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Microenvironment of chronic lymphocytic leukaemia

Dr George Follows, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
Microenvironment of chronic lymphocytic leukaemia ( Dr George Follows, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK )
29 Apr 2016

Chronic lymphocytic leukaemia: Transition to a new era

Prof Stephen Mulligan - Royal North Shore Hospital, Australia
Chronic lymphocytic leukaemia: Transition to a new era ( Prof Stephen Mulligan - Royal North Shore Hospital, Australia )
29 Apr 2016

Ibrutinib as a frontline therapy in RESONATE2 trials for CLL

Prof Jan Burger, MD Anderson Cancer Center, Texas, USA
Ibrutinib as a frontline therapy in RESONATE2 trials for CLL ( Prof Jan Burger, MD Anderson Cancer Center, Texas, USA )
29 Apr 2016

The role of the microenvironment and novel therapies in CLL

Prof Jan Burger - MD Anderson Cancer Center, Texas, USA
The role of the microenvironment and novel therapies in CLL ( Prof Jan Burger - MD Anderson Cancer Center, Texas, USA )
29 Apr 2016

Multi-target S-DNA increases colorectal cancer screening among previously non-compliant patients

Dr Barry Berger - Exact Sciences, Madison, USA
Multi-target S-DNA increases colorectal cancer screening among previously non-compliant patients ( Dr Barry Berger - Exact Sciences, Madison, USA )
29 Apr 2016

p62: Metabolism and the tumour microenvironment

Prof Jorge Moscat - Sanford Burnahm Prebys Medical Discovery Institute, La Jolla, USA
p62: Metabolism and the tumour microenvironment ( Prof Jorge Moscat - Sanford Burnahm Prebys Medical Discovery Institute, La Jolla, USA )
29 Apr 2016

Cancer cells plasticity and drug resistance

Dr Rafaella Sordella - Cold Harbor Spring Laboratory, New York, USA
Cancer cells plasticity and drug resistance ( Dr Rafaella Sordella - Cold Harbor Spring Laboratory, New York, USA )
29 Apr 2016

Targeted therapy shows continued promise in patients whose tumours had NTRK gene fusions

Dr David Hong - University of Texas MD Anderson Cancer Center, Houston, USA
Targeted therapy shows continued promise in patients whose tumours had NTRK gene fusions ( Dr David Hong - University of Texas MD Anderson Cancer Center, Houston, USA )
29 Apr 2016

Editor's Choice for April 2016

Prof Gordon McVie - ecancer Editor
Editor's Choice for April 2016 ( Prof Gordon McVie - ecancer Editor )
29 Apr 2016

Drugging “undruggable” transcription factor drivers in cancer

Dr John Bushweller - Unviersity of Virgina, Virginia, USA
Drugging “undruggable” transcription factor drivers in cancer ( Dr John Bushweller - Unviersity of Virgina, Virginia, USA )
28 Apr 2016

Pembrolizumab yielded durable responses in patients with advanced Merkel cell carcinoma

Dr Paul Nghiem - University of Washington, Seattle, USA
Pembrolizumab yielded durable responses in patients with advanced Merkel cell carcinoma ( Dr Paul Nghiem - University of Washington, Seattle, USA )
28 Apr 2016

Combination therapy before surgery improves outcomes for patients with HER2 positive breast cancer

Dr Angela DeMichele - Perelmen School of Medicine, University of Pennsylvania, Philadelphia, USA
Combination therapy before surgery improves outcomes for patients with HER2 positive breast cancer ( Dr Angela DeMichele - Perelmen School of Medicine, University of Pennsylvania, Philadelphia, USA )
28 Apr 2016